Tag: Additional
Rakuten Medical Secures Additional Investment from Rakuten to Further Develop its Photoimmunotherapy Platform Capabilities

Rakuten Medical Secures Additional Investment from Rakuten to Further Develop its Photoimmunotherapy Platform Capabilities

Investment to also support pipeline growth, and global business and commercial expansion SAN MATEO, California and TOKYO, August 2, 2019 /PRNewswire/ -- Rakuten Medical, Inc., ...

Lees verder
Venture Global LNG Raises $675 Million of Additional Capital

Venture Global LNG Raises $675 Million of Additional Capital

ARLINGTON, Virginia, June 27, 2019 /PRNewswire/ -- Venture Global LNG, Inc. announces that it has raised $675 million of additional capital from world-class institutional ...

Lees verder
Venture Global LNG Announces Additional Private Placement Funding of $160 Million: Aggregate Funding Total Reaches $630 Million

Venture Global LNG Announces Additional Private Placement Funding of $160 Million: Aggregate Funding Total Reaches $630 Million

ARLINGTON, Virginia, Aug. 16, 2018 /PRNewswire/ -- Venture Global LNG, Inc. announces that it has raised additional private capital of approximately $160 million from large ...

Lees verder
Boreal Intercepts Additional High-Grade Zinc Silver Lead at Gumsberg, Sweden

Boreal Intercepts Additional High-Grade Zinc Silver Lead at Gumsberg, Sweden

VANCOUVER, British Columbia, May 2, 2018 /PRNewswire/ -- Boreal Metals Corp. ("Boreal" or the "Company") is pleased to announce additional drill results from a recently ...

Lees verder
German Federal Joint Committee (G-BA) Confirms Evidence for Additional Benefit for CINQAERO® (reslizumab) in Severe Asthma Patients with an Eleva

German Federal Joint Committee (G-BA) Confirms Evidence for Additional Benefit for CINQAERO® (reslizumab) in Severe Asthma Patients with an Eleva

AMSTERDAM, July 6, 2017 /PRNewswire/ -- Positive Assessment in Germany Brings More Patients Closer to Gaining Access to CINQAERO(R)   Teva Pharmaceuticals Europe BV, today ...

Lees verder
Data Provide Additional Insight Into the Mode of Action of MAVENCLAD(TM) (Cladribine Tablets) in Patients With Relapsing MS

Data Provide Additional Insight Into the Mode of Action of MAVENCLAD(TM) (Cladribine Tablets) in Patients With Relapsing MS

DARMSTADT, Germany, June 26, 2017 /PRNewswire/ -- - Data suggest that MAVENCLAD(TM) (Cladribine Tablets) selectively and discontinuously reduces B and T ...

Lees verder
BizPress.nl